Ritonavir Completed Phase 2 Trials for Hepatitis D Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02511431Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir